Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/19/2025

Investigations to Rule Out Secondary Hypertension

Introduction to Secondary Hypertension

  • The European Society of Cardiology recommends screening for secondary hypertension when patients present with age of onset <30 or >50 years, resistant hypertension, sudden onset or deterioration of previously controlled hypertension, hypertensive urgency/emergency, or target organ damage disproportionate to hypertension duration 1, 2

Clinical Evaluation

  • Age-related clues, such as onset before age 30, suggest fibromuscular dysplasia, coarctation, or endocrine disorders, while onset after age 50 suggests atherosclerotic renovascular disease 1, 2
  • Resistant hypertension, requiring >3 medications from different classes, is the strongest clinical indicator 1, 2
  • Specific symptoms, such as muscle weakness, tetany, or arrhythmias, suggest primary aldosteronism, while episodic sweating, palpitations, or headaches suggest pheochromocytoma 1, 2

Basic Laboratory Investigations

  • The European Society of Cardiology 2024 guidelines recommend measuring aldosterone-to-renin ratio in all adults with confirmed hypertension, representing a major departure from traditional selective screening 2
  • Serum electrolytes, including sodium and potassium, should be measured, as unprovoked hypokalemia suggests primary aldosteronism or renovascular disease 1, 2
  • Renal function, including serum creatinine and estimated glomerular filtration rate, should be assessed 1, 2, 4

Targeted Advanced Investigations

  • For primary aldosteronism, the aldosterone-to-renin ratio should be measured, and confirmatory testing, such as intravenous saline suppression test or oral sodium loading test, should be performed if the ratio is high 1, 2
  • For renovascular disease, renal ultrasound with Doppler duplex should be performed as initial non-invasive screening, followed by CT or MR angiography for precise localization of stenosis 1, 2, 4
  • For pheochromocytoma, plasma free metanephrines or 24-hour urinary catecholamines/metanephrines should be measured, and abdominal/adrenal imaging should be performed after biochemical confirmation 1, 2

Imaging Studies

  • Echocardiography should be performed to evaluate left ventricular hypertrophy, systolic/diastolic dysfunction, atrial dilation, and aortic coarctation 1, 2
  • Carotid ultrasound should be performed to assess for plaques and stenosis 1

Diagnostic Algorithm

  • A stepwise approach should be followed, starting with basic screening and advancing to specialized testing only when clinical clues warrant further investigation 1, 2

Critical Pitfalls to Avoid

  • Failure to recognize drug-induced or substance-induced hypertension before extensive workup is a common and costly error 1
  • Medication review is essential, as oral contraceptives, NSAIDs, decongestants, glucocorticoids, cyclosporine, cocaine, and amphetamines can all cause hypertension 3, 1

Prevalence Context

  • Secondary hypertension affects 5-10% of all hypertensive patients, but this increases substantially in resistant hypertension populations, where specific causes like primary aldosteronism and OSA are much more common 2

REFERENCES

1

Diagnostic Approach to Secondary Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Secondary Causes of Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Diagnostic Criteria for Renal Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025